Home

Lind Global Fund III reported a 4.96% stake in Silexion Therapeutics SLXN · 212,500 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4.96%
Last report
6.4% · filed 25/11/14
Shares held
212,500 sh
Class
Ordinary shares, par value $0.0135 per share
Event date
26/03/31
Filed
26/05/15

4.96% stake · below 5%

Stake
4.96%
Last report
6.4%
Since last report
−1.4pp

Silexion Therapeutics trades, last 26 weeks

What else happened in Silexion Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Lind Global Fund III's other 5% stake reports

  • Lind Global Fund III

    5% stakeDare Bioscience

    5.65% stake

    Filed 08/28

  • Lind Global Fund III

    5% stakeDefsec Technologies

    9.99% stake

    Filed 08/25

  • Lind Global Fund III

    5% stakeEnveric Biosciences

    1.4% stake

    Filed 08/14

  • Lind Global Fund III

    5% stakeNuwellis

    6.2% stake

    Filed 08/05

  • Lind Global Fund III

    5% stake60 Degrees Pharmaceuticals

    5.45% stake

    Filed 08/05